What is Serratiopeptase?
Serratiopeptase, also called serrapeptase, is a proteolytic enzyme originally derived from bacteria found in silkworms. It belongs to the trypsin family of enzymes and works by breaking down proteins into smaller molecules. In medicine, this means it can help reduce swelling, clear damaged tissue, and promote healing without harming healthy cells.
First used in Japan in the 1950s, serratiopeptase became popular in Europe in the 1980s and 1990s, where research found it to be more effective at controlling inflammation than other enzymes in its class. Today, it is used in orthopedics, dentistry, gynecology, cardiac care, and postoperative recovery.
Conditions It May Help Treat
Studies and clinical use suggest serratiopeptase may benefit:
- Arthritis and joint pain
- Neurological disorders, including Alzheimer’s
- Heart disease and atherosclerosis
- Sinusitis and bronchitis
- Fibrocystic breast disease
- Carpal tunnel syndrome
- Bone and joint infections
- Postoperative swelling and wound healing
Its appeal lies in its ability to reduce inflammation and pain while generally causing fewer side effects than common anti-inflammatory drugs like NSAIDs.
How It Works
Serratiopeptase appears to work in several ways:
- Anti-inflammatory: Regulates immune cell activity and reduces inflammatory molecules such as cyclooxygenase and bradykinin.
- Fibrinolytic: Breaks down fibrin, the protein involved in blood clotting, which may reduce clot risk and help prevent plaque buildup in arteries.
- Anti-biofilm: Disrupts bacterial biofilms, making infections easier to treat with antibiotics.
- Wound healing: Clears dead tissue, reduces swelling, and improves blood flow at injury sites.
Research and Evidence
Much of the early research comes from Japan and Europe, with additional studies in India and other regions. Findings suggest serratiopeptase can speed recovery from surgery, reduce swelling from injuries, and relieve symptoms of chronic sinusitis. It has also shown potential in supporting antibiotic treatment for infections involving biofilms.
However, some reviews, including one published in the International Journal of Surgery, point out that many studies have small sample sizes, short durations, or poor methodology. Critics argue that while it shows promise, stronger clinical trials are needed before its benefits can be fully confirmed.
Availability and Recommendations
Serratiopeptase is widely available as a dietary supplement in the United States, Canada, India, and parts of Europe. In Canada, it is approved as a natural health product for reducing pain and swelling. In India, it is sold as a pharmaceutical ingredient, often in combination with other drugs. In Japan, it was voluntarily withdrawn by its main manufacturer in 2011.
Typical doses in studies range from 10 to 60 milligrams per day, most often taken on an empty stomach. Lower doses of around 5 milligrams may help with mild discomfort. Because it can interact with blood thinners and some other medications, medical guidance is recommended before starting supplementation.
Safety and Side Effects
Serratiopeptase is generally well tolerated, but possible side effects include digestive upset, skin reactions, muscle aches, or increased risk of bleeding. Rare cases of serious reactions, such as Stevens-Johnson syndrome, have been reported. Side effects may be dose-related or occur when combined with certain drugs.
The Bottom Line
Serratiopeptase has been used for decades to treat inflammation, pain, and related conditions. It offers potential advantages over traditional anti-inflammatory drugs, especially for patients who cannot tolerate NSAIDs. While many clinical and anecdotal reports highlight its benefits, the scientific community calls for larger, better-controlled trials to determine its true efficacy and long-term safety.
If used, it should be taken under medical supervision—particularly by those on other medications or with conditions that affect bleeding or immune function.
